EpiPen

Tthe government rarely steps in. Shouldn’t the FDA revisit its role to ensure it is striking the appropriate balance between protecting patients from flawed drugs and ensuring drugs get to market to reduce prices?Tthe government rarely steps in. Shouldn’t the FDA revisit its role to ensure it is striking the appropriate balance between protecting patients from flawed drugs and ensuring drugs get to market to reduce prices?